Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-03-03 @ 10:05 AM
Study NCT ID:
NCT00972933
Status:
COMPLETED
Last Update Posted:
2017-12-07
First Post:
2009-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
Sponsor:
Diwakar Davar
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2013-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-03
First Submit QC Date:
None
Study First Post Date:
2009-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-05
Last Update Post Date:
2017-12-07
Last Update Post Date Type:
ACTUAL